Diagnosis and management of attention-deficit/hyperactivity disorder in children

Current Opinion in Pediatrics

Volumn 13, Issue 2, 2001, Pages 190-199

  Kirby, Kelly ^a,b,c   Floriani, Victoria ^b   Bernstein, Henry ^b  

^a MASSACHUSETTS COLLEGE OF PHARMACY AND HEALTH SCIENCES   (United States)

^b BOSTON CHILDREN S HOSPITAL   (United States)

^c MCHPS Boston   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMFEBUTAMONE; AMPHETAMINE; ANTIDEPRESSANT AGENT; CLONIDINE; FISH OIL; FOOD ADDITIVE; GINKGO BILOBA EXTRACT; GUANFACINE; IMIPRAMINE; MAGNESIUM; MELATONIN; METHYLPHENIDATE; NORTRIPTYLINE; PEMOLINE; PLACEBO; PRIMROSE OIL; PSYCHOSTIMULANT AGENT; PYRIDOXINE; ZINC;

ATTENTION DEFICIT DISORDER; BEHAVIOR THERAPY; CHILD; CHILDHOOD DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIET RESTRICTION; DOUBLE BLIND PROCEDURE; DRUG ABUSE; DRUG FORMULATION; HERBAL MEDICINE; HUMAN; HYPERACTIVITY; LIVER TOXICITY; MAJOR CLINICAL STUDY; NUTRITIONAL DEFICIENCY; OSMOTIC PUMP; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; RANDOMIZED CONTROLLED TRIAL; REVIEW; SUSTAINED RELEASE PREPARATION; VITAMIN INTAKE;

ADRENERGIC ALPHA-ANTAGONISTS; ANTIDEPRESSIVE AGENTS, TRICYCLIC; ATTENTION DEFICIT DISORDER WITH HYPERACTIVITY; BEHAVIOR THERAPY; CENTRAL NERVOUS SYSTEM STIMULANTS; CHILD; HUMANS;

EID: 0035040704     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/00008480-200104000-00019     Document Type: Review

References (40)

1. Clinical Practice Guideline: Diagnosis and evaluation of the child with attention-deficit/hyperactivity disorder
2. Diagnosis and treatment of attention-deficit/hyperactivity disorder (ADHD)
3. Commentary
4. Stimulant treatment for children: A community perspective
5. Commentary
6. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder
7. Are stimulants overprescribed? Treatment of ADHD in four US communities
8. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder. The multimodal treatment study of children with attention-deficit/hyperactivity disorder
9. ADHD: A new practice guideline from the American Academy of Pediatrics
10. What the multimodal treatment study of children with attention-deficit/hyperactivity disorder did and did not say about the use of methylphenidate for attention deficits
11. Attention-deficit hyperactivity disorder in children and youth: A quantitative systematic review of the efficacy of different management strategies
12. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part I
13. The Texas Children's Medication Algorithm Project: Report of the Texas Consensus Conference Panel on medication treatment of childhood attention-deficit/hyperactivity disorder. Part I
14. A comparison of Ritalin and Adderall: Efficacy and time-course in children with attention-deficit/hyperactivity disorder
15. Objective and subjective measures of the pharmacodynamic effects of Adderall in the treatment of children with ADHD in a controlled laboratory classroom setting
16. A comparison of morning-only and morning/late afternoon Adderall to morning-only, twice-daily, and three-times-daily methylphenidate in children with attention-deficit/hyperactivity disorder
17. A double blind, placebo-controlled study of Adderall and methylphenidate in the treatment of attention-deficit/hyperactivity disorder
18. Placebo-controlled evaluation of amphetamine mixture-dextroamphetamine salts and amphetamine salts (Adderall): Efficacy rate and side effects
19. A new long-acting methylphenidate (Concerta)
20. Intranasal abuse of prescribed methylphenidate
21. A fatality due to the intranasal abuse of methylphenidate
22. On campus Ritalin getting attention as a "good buzz."
23. "As easy to get as candy" A new Mass [Massachusetts] study finds wide teen abuse of Ritalin
24. Methylphenidate and cocaine have a similar in vivo potency to block transporters in the human brain
25. Methylphenidate: Increased abuse or appropriate use?
26. Alternative (nonstimulant) medications in the treatment of attention-deficit/hyperactivity disorder in children
27. Alternative and controversial treatments for attention-deficit/hyperactivity disorder
28. "At least it's natural ..." Herbs and dietary supplements in ADHD
29. Utilization of alternative therapies in attention-deficit hyperactivity disorder
30. Does zinc moderate essential fatty acid and amphetamine treatment of attention-deficit/hyperactivity disorder?
31. The effects of essential fatty acid supplementation by Efarnol in hyperactive children
32. Incorporating the management of ADHD into your practice: Can it be done?
33. Managing ADHD in general practice. N of 1 trials can help!